Company
Adela
Adela is advancing the field of epigenomics to transform how cancer is detected and monitored.
Also known as Adela, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Foster City, CA, United States
- Customers
- biopharmaceutical companies and other investigators
- Legal name
- Adela, Inc.
Claim, correct or request removal
Record updated 23 October 2026
About
By leveraging proprietary methylome analysis technology and cutting-edge data science, Adela delivers highly sensitive, blood-based tests that uncover critical insights from cell-free DNA.
Funding snapshot
- Total raised
- $113MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Undisclosed, $12M2026-10-02
Funding rounds
- Round, 2026
- $12M2026-10-02, SEC form D sold
- Round, 2026
- $5M2026-04-10, SEC form D sold, 1 investor
- Round, 2025
- $25.4M2025-06-23, SEC form D sold, 9 investors
- Round, 2023
- $3.3M2023-10-10, SEC form D sold, 3 investors
- Round, 2023
- $48.5M2023-07-28, SEC form D sold, 11 investors
- Round, 2021
- $1.2M2021-07-14, SEC form D sold, 2 investors
- Round, 2021
- $30M2021-03-17, SEC form D sold, 7 investors
Products
- Other
- Blood-based clinical testing for cancer detection and monitoring
Loading relationship preview